AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Pre-Tax Income
AstraZeneca PLC
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Pre-Tax Income
$6.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
8%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Pre-Tax Income
£6.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Pre-Tax Income
-$53.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Pre-Tax Income
$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Pre-Tax Income
$281m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Pre-Tax Income
-£36.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's Pre-Tax Income?
Pre-Tax Income
6.9B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Pre-Tax Income amounts to 6.9B USD.
What is AstraZeneca PLC's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
8%
Over the last year, the Pre-Tax Income growth was 176%. The average annual Pre-Tax Income growth rates for AstraZeneca PLC have been 21% over the past three years , 28% over the past five years , and 8% over the past ten years .